Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
15 studies found for:    cerebral palsy | United States, Washington
Show Display Options
Rank Status Study
1 Completed
Has Results
Orthotics in Ambulatory Cerebral Palsy
Condition: Cerebral Palsy
Interventions: Device: SAFO worn;   Other: SAFO not worn
2 Completed Botulinum Toxin (BOTOX) for Cerebral Palsy
Conditions: Cerebral Palsy;   Muscle Spasticity
Intervention: Drug: Botulinum toxin type A
3 Completed Activity and Participation in Ambulatory Cerebral Palsy
Condition: Cerebral Palsy
Intervention:
4 Recruiting Intensive Home-based Treadmill Training and Walking Attainment in Young Children With Cerebral Palsy
Condition: Cerebral Palsy
Interventions: Other: home-based treadmill training;   Device: Treadmill
5 Unknown  Relaxation Training to Decrease Pain and Improve Function in Adolescents With Cerebral Palsy
Condition: Cerebral Palsy
Intervention: Behavioral: biofeedback-monitored relaxation training
6 Active, not recruiting On Track: Monitoring Development of Children With Cerebral Palsy or Gross Motor Delay
Condition: Cerebral Palsy
Intervention:
7 Completed
Has Results
Safety and Tolerability of Dalfampridine in Subjects With Cerebral Palsy
Condition: Cerebral Palsy (CP)
Interventions: Drug: dalfampridine-ER 10mg;   Other: Placebo
8 Completed Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity
Conditions: Spasticity;   Cerebral Palsy
Intervention: Drug: baclofen
9 Recruiting High-dose Erythropoietin for Asphyxia and Encephalopathy
Conditions: Neonatal Encephalopathy;   Birth Asphyxia
Interventions: Drug: Normal saline placebo;   Drug: Erythropoietin
10 Recruiting BOTOX® Open-Label Treatment in Pediatric Lower Limb Spasticity
Conditions: Pediatrics;   Muscle Spasticity;   Cerebral Palsy
Intervention: Biological: botulinum toxin Type A
11 Recruiting BOTOX® Treatment in Pediatric Lower Limb Spasticity
Conditions: Pediatrics;   Muscle Spasticity;   Cerebral Palsy
Interventions: Biological: botulinum toxin Type A;   Drug: Normal Saline (Placebo)
12 Recruiting BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity
Conditions: Pediatrics;   Muscle Spasticity;   Cerebral Palsy;   Stroke
Intervention: Biological: botulinum toxin Type A
13 Recruiting BOTOX® Treatment in Pediatric Upper Limb Spasticity
Conditions: Pediatrics;   Muscle Spasticity;   Cerebral Palsy;   Stroke
Interventions: Biological: botulinum toxin Type A;   Drug: Normal Saline (Placebo)
14 Active, not recruiting Open-Label and Single-Arm Study of MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adults
Condition: Sialorrhea
Intervention: Drug: MYOBLOC
15 Completed
Has Results
Safety and Efficacy Study of Oral Fampridine-SR in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Placebo;   Drug: 10 milligram (mg) fampridine-SR (4-aminopyridine, 4-AP);   Drug: 15 mg fampridine-SR (4-aminopyridine, 4-AP);   Drug: 20 mg fampridine-SR (4-aminopyridine, 4-AP)

Study has passed its completion date and status has not been verified in more than two years.